2,319 regulatory filings were published by NSE- and BSE-listed companies on 17 August 2026 — showing page 24 of 24.
Veerhealth Care Ltd · 511523 · BSE ·
<b>Q1FY27 Financials:</b> Reported its highest-ever quarterly total income of <b>₹25.09 Cr</b> (up 388% YoY) and a Net Profit of <b>₹1.23 Cr</b> (up 412% YoY). <b>Major New Orders:</b> Secured significant new orders in FY27, including a <b>₹18.24 Cr</b> order from a leading India…
Veerhealth Care Ltd · 511523 · BSE ·
**Stellar Q1FY27 Results:** Net Profit (PAT) soared by **412.50%** YoY to ₹1.23 Crore, while Total Revenues grew **388.13%** YoY to ₹25.09 Crore. **Major USFDA Clearance:** The company received USFDA clearance for its plant, enabling the export of Drug (OTC) products to the USA.…
Hero MotoCorp Limited · HEROMOTOCO · NSE ·
**Appointment:** Mr. Srihari Mulgund has been appointed as the new **Chief Strategy Officer**, effective August 17, 2026. He will be designated as Senior Management Personnel. **Appointee Profile:** Mr. Mulgund has over 24 years of global automotive experience in engineering, pro…
Hero MotoCorp Limited · HEROMOTOCO · NSE ·
• Mr. Srihari Mulgund has been appointed as the new **Chief Strategy Officer**, effective August 17, 2026. • He brings over 24 years of global automotive experience from previous leadership roles at EY-Parthenon, Ricardo Strategic Consulting, and Aisin AW. • As part of the Leader…
Schneider Electric Infrastructure Limited · SCHNEIDER · NSE ·
<b>Record Orders:</b> Secured its highest-ever quarterly order intake of ₹ 915 cr, driven by major wins in Data Centers and Semiconductors. <b>Profitability Hit:</b> Profit After Tax (PAT) declined sharply by 69.8% YoY to ₹ 12.4 cr, significantly impacted by higher commodity cost…
Schneider Electric Infrastructure Limited · SCHNEIDER · NSE ·
Achieved highest-ever quarterly order intake of ₹915 crore, marking a significant milestone for the company. Profit After Tax (PAT) plunged 69.8% year-over-year to ₹12.4 crore, primarily due to rising commodity costs and a time lag in passing on price hikes to customers. Sales gr…
Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·
A U.S. Court of Appeals has ruled in favor of Sun Pharma in the long-running Lipitor antitrust litigation. The court affirmed a prior summary judgment granted to the company and also upheld the denial of class certification to the plaintiffs. This decision brings the litigation "…
Sun Pharmaceutical Industries Limited · SUNPHARMA · NSE ·
A U.S. Court of Appeals has affirmed a summary judgment *in its entirety in favour of the Company* in the long-standing Lipitor antitrust litigation. The ruling is a significant de-risking event, removing a major contingent liability and bringing the litigation substantially to a…
Aurobindo Pharma Limited · AUROPHARMA · NSE ·
The USFDA has concluded its inspection of the Raleigh, NC plant, classifying it as "Voluntary Action Indicated" (VAI), a positive outcome. This positive classification means the inspection, which initially had 11 observations, is now officially closed. Crucially, this allows pend…
Aurobindo Pharma Limited · AUROPHARMA · NSE ·
• The US Food and Drug Administration (USFDA) has concluded its inspection of the company's Raleigh, NC manufacturing facility. • The facility received a positive "Voluntary Action Indicated" (VAI) classification, resolving the 11 observations previously issued. • This allows pen…
Kotak Mahindra Bank Limited · KOTAKBANK · NSE ·
**Strong Profitability**: Consolidated Profit After Tax (PAT) surged 26% YoY to ₹4,123 crore for Q1FY27. **Robust Growth**: Net Advances grew by a strong 15% YoY to ₹5.12 lakh crore, driven by a 20% YoY growth in the Institutional Banking segment. **Improved Asset Quality**: Asse…
Kotak Mahindra Bank Limited · KOTAKBANK · NSE ·
The bank filed its August 2026 Investor Presentation for Q1FY27 (quarter ended June 30, 2026). <b>Consolidated Profit After Tax (PAT):</b> Grew 26% YoY to ₹4,123 cr. <b>Loan & Deposit Growth:</b> Net Advances increased by 15% YoY to ₹512,249 cr, and Deposits grew by 12% YoY to ₹5…
Kotak Mahindra Bank Limited · KOTAKBANK · NSE ·
Consolidated Profit After Tax (PAT) surged 26% YoY to ₹ 4,123 cr for Q1FY27. Net Advances grew 15% YoY to ₹ 512,249 cr, driven by strong performance in SME (↑20%) and Corporate Banking (↑15%). Asset quality strengthened, with Gross NPA improving to 1.18% and Net NPA to 0.27%. The…
Kotak Mahindra Bank Limited · KOTAKBANK · NSE ·
Consolidated Profit After Tax (PAT) surged 26% YoY to ₹4,123 Crores for the quarter ended June 30, 2026. Net Advances grew 15% YoY to ₹5.12 lakh crores, driven by strong performance in Institutional Banking (20% YoY growth). Asset quality remains robust with Net NPA at a low 0.27…
Kotak Mahindra Bank Ltd · 500247 · BSE ·
**Consolidated PAT:** Grew **26% YoY** to **₹4,123 cr** for Q1 FY27. **Net Interest Income (NII):** Increased by 9% YoY to ₹7,928 cr. **Advances & Deposits:** Net Advances grew **15% YoY** to ₹5.12 lakh cr; Deposits up **12% YoY** to ₹5.72 lakh cr. **Asset Quality:** Stable with…
Kotak Mahindra Bank Ltd · 500247 · BSE ·
• <b>Strong Profitability:</b> Consolidated Profit After Tax (PAT) for Q1FY27 grew 26% YoY to ₹4,123 crore, driven by a 45% reduction in provisions. • <b>Loan Book Growth:</b> Total advances increased by 15% YoY to ₹5.27 lakh crore, led by a 20% rise in Institutional Banking. • <…
Yes Bank Limited · YESBANK · NSE ·
The filing is a revised Debt Investor Presentation for Q1 FY27 (quarter ended June 30, 2026), correcting a minor error in a previous version. **Q1 FY27 Financial Highlights:** Net Profit of ₹11 Bn, robust asset quality with Net NPA at 0.2%, and a strong CET-1 Ratio of 14.0%. **St…
Yes Bank Limited · YESBANK · NSE ·
• <b>Q1 FY27 Highlights:</b> Net Profit of INR 11 Bn, annualized Return on Assets (RoA) at 0.9%, and Net Interest Margin (NIM) at 2.7%. • <b>Strong Asset Quality:</b> Gross NPA stable at 1.3% and Net NPA at a low 0.2%, with a Provision Coverage Ratio of 81.7%. • <b>Robust Capital…
Yes Bank Limited · YESBANK · NSE ·
• The company filed a revised Debt Investor Presentation to correct a typographical error from a previous submission. The presentation covers performance as of June 30, 2026. • <b>Q1FY27 Performance:</b> Reported a Net Profit of ₹11 Bn and Net Interest Income of ₹28 Bn. Annualize…
